KADLIMATTI PHARMACEUTICALS

KADLIMATTI PHARMACEUTICALS is a Partnership Firm registered in Bagalkote, India and holds an LEI in its own name.

The LEI was issued in 2025. That is about 1 year later than the median LEI in India (2024).

The next annual re-validation is due 26 Nov 2026, 26 days from now.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The entity is registered with GST Portal under registry number 29AAVFK9996Q1ZH, and the LEI itself is issued and maintained by Nasdaq CSD SE, one of the Local Operating Units accredited by GLEIF.

No direct accounting-consolidating parent is reported, because its parent is one or more natural persons, who are outside the LEI system. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because its parent is one or more natural persons, who are outside the LEI system. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is issued, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.